Hexo(NYSE:HEXO) Managements

  • Symbol:NYSE:HEXO
  • Ticker 2:TSE:HEXO
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Sebastien St-Louis
  • Founded:2013

Hexo(NYSE:HEXO) Managements

Sebastien St-Louis

Co-founder & Chief Executive Officer

Sébastien St-Louis is an entrepreneur with strong leadership abilities, financial acumen and operational expertise. Sébastien has wide-ranging business experience in manufacturing, distribution, trade finance and commercial lending. He has advised Canadian business owners and CEOs across multiple industry sectors, while structuring and closing $200 million in financing to support their export and growth initiatives.

Sébastien co-founded HEXO Corp. with one goal in mind: to create a world-class company based on the highest standards of product quality and safety. Since 2013, he has secured more than $260 million dollars in financing for the company. His leadership has been instrumental in navigating the company through regulatory, financing and start-up challenges on route to becoming the only significant licensed cannabis producer in Quebec and, upon completion of two fully-funded expansion projects currently underway, one of the largest in Canada. Sébastien holds an MBA in Finance from the Université du Québec à Montréal and completed his Bachelor of Arts (Economics) from the University of Ottawa in 18 months.
Adam Miron


Adam Miron is an entrepreneur who has launched several successful businesses at the intersection of media, brand development, and public engagement. Adam’s ventures have included iPolitics, Canada’s premier online political news site.

Adam has been dedicated to public service throughout his adult life and has contributed to political campaigns at all levels of government. Among notable roles, he is a past National Director for Federal Commissions of the Liberal Party of Canada.

Adam turned his entrepreneurial talents to the medical cannabis industry and co-founded HEXO Corp. in 2013. Under his leadership as Chief Brand Officer, HEXO Corp. has emerged as one of Canada’s most innovative medical cannabis producers. Adam’s creativity continues to guide the development of the company’s industry-leading product line, including its award winning Decarb edible cannabis powder and Elixir sublingual peppermint oil cannabis spray, which won first and third place respectively in the Best New Cannabis Product category at the 2017 Canadian Cannabis Awards.
Dr. Michael Munzar, M.D.

Chair of the Board

Dr. Munzar has four decades of clinical experience as a licensed physician in Quebec. He has managed medical facilities and designed and conducted pre-clinical studies and clinical trials across the health care spectrum. His experience includes serving as Vice President of Medical and Regulatory Affairs at Osta Biotechnologies Inc., President of Serex Inc., and Medical Director of Nymox Pharmaceutical Corporation. Dr. Munzar’s work has been published in numerous peer-reviewed journals. Currently Dr. Munzar is an owner and medical director of Statcare Medical Clinic in Point-Claire, Quebec this clinic is provincial accredited and funded as a Super-Clinic (GMF-Réseau) that sees and treats over 50,000 patients per year.

Dr. Munzar brings a wealth of medical and pharmaceutical industry and business experience to the board. He also serves as HEXO Corp.’s medical director. His scientific rigour and excellence have contributed to the quality of our research and the excellence of our products. He is a graduate of Bishop’s University (BSc Hon. Organic Chemistry) and received his MDCM from McGill University in 1979.
Steve Burwash

Chief Financial Officer

Steve Burwash brings a wealth of experience in global finance and operations to his role of Chief Financial Officer. Steve has held senior management positions in the aerospace and defense, telecommunications and manufacturing industries. Most recently Steve held management positions at Mitel Networks where he led financial planning and analysis for the Cloud division and led the company’s financial integration and business process optimization across 12 countries.

Steve has an MBA from the University of Ottawa and boasts over 25 years of proven expertise in acquisitions, due diligence to integration, financial governance and process optimization.
Jason Ewart


Jason Ewart is an accomplished financial executive with a track record of success in the venture capital and private equity sectors. Presently he is the co-founder, Director and EVP Capital Markets for Uptempo Inc., a U.S. fintech company with over 40,000 customers covering 12 states, that offers a payment concierge service.

Jason is the co-founder and former CEO of the Canadian merchant bank, Fountain Asset Corp.

He currently sits on the boards of Uptempo Inc., Bradstone Capital Corp., Attorneys Title Guarantee Fund Inc., and the Northumberland Community Futures Development Corp. Prior to this, Jason was a market analyst with A&E Capital Funding Inc. and Quest Investment Corporation between 1998 and 2003.

An Economics graduate from McGill University, Jason brings deep insight into finance, bridge financing, financial analysis, quantitative modeling, equities trading and mergers and acquisitions.
Donald Courtney

Chief Operating Officer

Donald Courtney boasts over 20 years of experience in senior operations positions across several industries, including previous experience in the cannabis industry. Donald has extensive experience with several global food and beverage organizations including Mars Inc., Pepsi Bottling Group and Vincor International and experience in technology with Christie Digital and LG Electronics. Most recently, Donald served as the Chief Operating Officer for MedReleaf. Donald is a graduate of Control Engineering from St. Lawrence College.

As Chief Operating Officer, Donald is focused on operational excellence and integrated business strategies.

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Become a Patron below and support us in covering the latest marijuana news!